3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride, 95.0%, 5g

1-[2-(Trifluoromethyl)phenyl]imidazole>98.0%(GC)1g

4-(2-Chloro-phenyl)-5-methyl-thiazol-2-ylamine, 95.0%, 1g

Tesevatinib, 99.21%, 5mg

Minzöl, doppelt rekt., 250 ml, Glasverpackung

Pyrimidine-2,4,5,6(1H,3H)-tetraone tetrahydrate, 95.0%, 10g

Tert-butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate, 98%, 10g

Methyl 4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 100mg

4-(4-Methylpiperazinyl)benzoic Acid>98.0%(HPLC)(T)5g

Ethyl 5-chloro-2-iodobenzoate, 95+%, 1g

2-Chloro-4-fluoro-3-methylpyridine, 97%, 250mg

(2-AMINO-4,6-DICHLOROPYRIMIDIN-5-YL)METHANOL, 95.0%, 1g

7-HEXADECANONE, 95%, 1g